These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16999231)

  • 1. Endothelial cells and cancer.
    Nikitenko L; Boshoff C
    Handb Exp Pharmacol; 2006; (176 Pt 2):307-34. PubMed ID: 16999231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Detransformation for Cancer Therapy.
    Fan Y
    Trends Cancer; 2019 Aug; 5(8):460-463. PubMed ID: 31421902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPCs and pathological angiogenesis: when good cells go bad.
    Li Calzi S; Neu MB; Shaw LC; Kielczewski JL; Moldovan NI; Grant MB
    Microvasc Res; 2010 May; 79(3):207-16. PubMed ID: 20188747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The involvement of endothelial progenitor cells in tumor angiogenesis.
    Ribatti D
    J Cell Mol Med; 2004; 8(3):294-300. PubMed ID: 15491505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
    Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
    Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth.
    Purhonen S; Palm J; Rossi D; Kaskenpää N; Rajantie I; Ylä-Herttuala S; Alitalo K; Weissman IL; Salven P
    Proc Natl Acad Sci U S A; 2008 May; 105(18):6620-5. PubMed ID: 18443294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphangiogenesis, lymphatic endothelial cells and lymphatic metastasis in head and neck cancer--a review of mechanisms.
    Zhang Z; Helman JI; Li LJ
    Int J Oral Sci; 2010 Mar; 2(1):5-14. PubMed ID: 20690413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis.
    Holopainen T; Saharinen P; D'Amico G; Lampinen A; Eklund L; Sormunen R; Anisimov A; Zarkada G; Lohela M; Heloterä H; Tammela T; Benjamin LE; Ylä-Herttuala S; Leow CC; Koh GY; Alitalo K
    J Natl Cancer Inst; 2012 Mar; 104(6):461-75. PubMed ID: 22343031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicular trafficking mechanisms in endothelial cells as modulators of the tumor vasculature and targets of antiangiogenic therapies.
    Maes H; Olmeda D; Soengas MS; Agostinis P
    FEBS J; 2016 Jan; 283(1):25-38. PubMed ID: 26443003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy?
    Rafii S; Lyden D; Benezra R; Hattori K; Heissig B
    Nat Rev Cancer; 2002 Nov; 2(11):826-35. PubMed ID: 12415253
    [No Abstract]   [Full Text] [Related]  

  • 12. Preexisting lymphatic endothelium but not endothelial progenitor cells are essential for tumor lymphangiogenesis and lymphatic metastasis.
    He Y; Rajantie I; Ilmonen M; Makinen T; Karkkainen MJ; Haiko P; Salven P; Alitalo K
    Cancer Res; 2004 Jun; 64(11):3737-40. PubMed ID: 15172976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Methionine Aminopeptidase 2 in Lymphangiogenesis.
    Esa R; Steinberg E; Dror D; Schwob O; Khajavi M; Maoz M; Kinarty Y; Inbal A; Zick A; Benny O
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and angiogenesis inhibitors in cancer.
    Giavazzi R; Taraboletti G
    Forum (Genova); 1999; 9(3):261-72. PubMed ID: 10504172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of endothelial progenitor cells in tumour vasculogenesis.
    Ding YT; Kumar S; Yu DC
    Pathobiology; 2008; 75(5):265-73. PubMed ID: 18931528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallels of Resistance between Angiogenesis and Lymphangiogenesis Inhibition in Cancer Therapy.
    Jones D
    Cells; 2020 Mar; 9(3):. PubMed ID: 32244922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
    Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
    Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The specific effect of 2-methoxyestradiol on lymphatic vascular endothelial cells.
    Imai S; Yoshida Y; Okamura T; Nagano K; Abe Y; Yoshikawa T; Kamada H; Nakagawa S; Tsunoda S; Tsutsumi Y
    Pharmazie; 2009 Mar; 64(3):214-6. PubMed ID: 19348346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial Progenitors in the Tumor Microenvironment.
    Testa U; Pelosi E; Castelli G
    Adv Exp Med Biol; 2020; 1263():85-115. PubMed ID: 32588325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of tumor endothelial cells.
    Hida K; Ohga N; Akiyama K; Maishi N; Hida Y
    Cancer Sci; 2013 Nov; 104(11):1391-5. PubMed ID: 23930621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.